Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Tetraspan vs Albumin in Renal Failure Patients
NCT00936247Phase 4Terminated
- Sponsor
- B. Braun
- Start
- Nov 2009
- Primary completion
- Sep 2010
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxyethyl starch 130/0.42 in hypovolemia, sponsored by B. Braun. Started Nov 2009; status: terminated.
02
Drugs
hydroxyethyl starch 130/0.42
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT00936247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936247.